Table 2. Tumour frequency among MPMT subgroups.
| Tumour type | All tumours (n=441) | Testing sent (n=234) | No testing sent (n=208) | Test+ve group (n =96) | Test−ve group (n=138) |
|---|---|---|---|---|---|
| Breast | 128 (29%) | 69 (29.5%) | 59 (28.3%) | 21 (21.9%) | 48 (34.8%) |
| Ovarian | 54 (12.2%) | 35 (14.9%) | 18 (8.6%) | 14 (14.6%) | 21 (15.2%) |
| Colorectal | 71 (16.1%) | 34 (14.5%) | 37 (17.8%) | 21 (21.9%) | 13 (9.4%) |
| Endometrial | 43 (9.7%) | 28 (12%) | 16 (7.7%) | 12 (12.5%) | 16 (11.6%) |
| Non-melanoma skin | 42 (9.5%) | 22 (9.4%) | 21 (10.1%) | 7 (7.3%) | 15 (10.9%) |
| Other tumours individually comprising <5% total | 103 (23.3%) | 46 (19.6%) | 57 (27.4%) | 21 (21.9%) | 25 (18.1%) |